Many patients report subtle or noticeable changes in food preferences within the first month of starting treatment, ranging from decreased cravings for sweet or fatty foods to altered salt perception
Clinical translation requires human CSF pharmacokinetic assays to prove BBB bypass, a rigorous dose-escalation Phase I trial to establish a safe human NOAEL for chronic dosing, and an RCT utilizing precise neurocognitive testing (e.g., MoCA) to confirm that murine transcriptomic shifts yield functional neuroprotection in humans
If you forget to take your semaglutide dose, administer it as soon as you remember, provided its within five days of your regularly scheduled dose
Crash diets are counterproductive on a GLP-1
FDA-approved for type 2 diabetes as Mounjaro (2022) and for chronic weight management as Zepbound (2023)
Manufacturing processes matter significantly